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Abstract 
Alzheimer’s Disease (AD) is one of the most concerned neurodegenerative diseases. In the last 
decade, studies on AD diagnosis attached great significance to artificial intelligence (AI)-based 
diagnostic algorithms. Among the diverse modality imaging data, T1-weighted MRI and 18F-FDG-
PET are widely researched for this task. In this paper, we propose a novel convolutional neural 
network (CNN) to fuse the multi-modality information including T1-MRI and FDG-PDT images 
around the hippocampal area for the diagnosis of AD. Different from the traditional machine 
learning algorithms, this method does not require manually extracted features, and utilizes the state-
of-art 3D image-processing CNNs to learn features for the diagnosis and prognosis of AD. To 
validate the performance of the proposed network, we trained the classifier with paired T1-MRI and 
FDG-PET images using the ADNI datasets, including 731 Normal (NL) subjects, 647 AD subjects, 
441 stable MCI (sMCI) subjects and 326 progressive MCI (pMCI) subjects. We obtained the 
maximal accuracies of 90.10% for NL/AD task, 87.46% for NL/pMCI task, and 76.90% for 
sMCI/pMCI task. The proposed framework yields comparative results against state-of-the-art 
approaches. Moreover, the experimental results have demonstrated that (1) segmentation is not a 
prerequisite by using CNN, (2) the hippocampal area provides enough information to give a 
reference to AD diagnosis.  
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1. Introduction 
The aging of global population results in increasing number of people with dementia. Recent studies 
indicate 50 million people are living with dementia [1], of whom 60%-70% have Alzheimer’s 
Disease (AD) [2]. Known as one of the most common neurodegenerative diseases, AD can result in 
severe cognitive impairment and behavior issue. 
 
With the progression of AD, the structure and metabolic rate of the brain change. The phenotype 
includes the shrinkage of cerebral cortices and hippocampi, the enlargement of ventricles, and the 
change of regional glucose uptake. These changes can be quantified with the help of medical 
imaging techniques such as magnetic resonance imaging (MRI), positron-emission tomography 
(PET) and computed tomography (CT) [3]. For instance, T1-weighted MRI provides high-
resolution structural information of the brain, enabling the measurement of structural metrics such 
as thickness, volume and shape. Meanwhile, 18F-FDG-PET indicates the regional cerebral metabolic 
rate of glucose, making it possible to evaluate the metabolic activity of tissues. By computing and 
analyzing from these medical images, one can obtain important reference to assist the diagnosis and 
the prediction of AD [4]. 
 
Mild cognitive impairment (MCI) is a neurological disorder which involves cognitive impairments 
with minimal impairment in instrumental activities of daily living [5]. MCI involves the onset and 
evolution of cognitive impairments beyond a normal expectation of an individual's age and 
education, but which are not significant enough to interfere with her or his daily activities [6]. It 
may occur as a transitional stage between normal aging and the preclinical phase of dementia. MCI 
is a large heterogeneous group because of its variety of clinical outcomes [7]. In this work, we 
classified MCI into progressive mild cognitive impairment (pMCI) and stable mild cognitive 
impairment (sMCI), which are retrospective diagnostic terms based on the clinical follow-up. As 
pMCI refers to the MCI subjects who converted to dementia according to the DSM-IV criteria 
during the follow-up [8], sMCI is defined when the subjects do not fulfill the criteria. Identification 
between pMCI and sMCI plays an important role for the early diagnosis of dementia, which can 
assist clinicians to propose effective therapeutical interventions of the disease process [9]. 
 
This work aims at differentiating AD or potential AD patients from normal subjects accurately and 
automatically using medical images around the hippocampal area and recent technologies in deep 
learning. This facilitates a fast-preclinical diagnosis. The method is further extended for the 
classification between sMCI and pMCI so that an early diagnosis of dementia would be possible. 
 
In our proposed method, multi-modality data were used. We used two modalities in our experiments 
including the T1-weighted MRI and 18F-FDG-PET. Up to now, numerous studies have been 
published on diagnosing AD by utilizing T1 MRI Sorensen et al. segmented the brains and extracted 
features like the thicknesses of cortices and volumes of tissues in the selected regions of interest 
(ROIs) [10]. After that they used linear discriminant analysis (LDA) to classify AD, MCI and 
normal (NL), and achieved 63.0% classification accuracy on the CADDementia dataset. David et 
al., implemented kernel metric learning in classification [11]. Based on the segmentation results 
provided by FreeSurfer, morphological features like cortical volume, surface area and thickness 
were extracted and utilized for further classification. In the end they obtained an overall accuracy 
of 60.1% on the CADDementia dataset. Another popular machine learning method is random forest. 
Lebedeva et al. extracted the cortical thickness and subcortical volumes as structure features of MRI 
and used mini-mental state examination (MMSE) as a cognitive measure [12]. Ardekani et al. took 
hippocampal volumetric integrity of MRI and neuropsychological scores as the selected features 
[13]. Both studies used random forest to implement the classification because random forest has 
been demonstrated as a feasible and reliable machine learning method for classification.  
 
The imaging data from18F-FDG-PET are widely used to observe metabolic processes in the body, 
including for diagnosis of AD. Silveira et al., proposed a boosting learning method which used a 
mixture of simple classifiers to perform voxel-wise feature selections. They achieved an accuracy 
of 90.97% in the detection of AD and 79.63% of MCI on the ADNI dataset [15]. Cabral et al., used 
favorite class ensembles to form ensembled SVM and random forest, and achieved 66.78% accuracy 
in AD, NL and MCI 3-class classification problem on the ADNI dataset [16]. 
 
In addition to the single modality classifications, taking both T1-weighted MRI and 18F-FDG-PET 
together is also a main concern of AD diagnosis. Gary et al., took regional MRI volumes, voxel-
based PET intensities, cerebrospinal fluid (CSF) biomarkers and genetic information as features and 
used random-forest-based similarity measures to classify AD and MCI from NL, and got 89% 
accuracy for AD/NL, and 75% for MCI/NL on the ADNI dataset [17]. Besides, Zhang et al., 
conducted classification based on MRI, PET and CSF biomarkers [18]. Using SVM, they obtained 
93.2% accuracy for AD/NL, and 76.4% for MCI/NL. Moreover, other imaging modalities or PET 
tracers can be taken into account, like Rondina et al., used T1-weighted MRI, 18F-FDG-PET and 
rCBF-SPECT as imaging modalities while Wang et al., took 18F-FDG and 18F-florbetapir as tracer 
of PET [19,20]. 
 
The studies mentioned above follow four steps in the diagnosis algorithms, namely data 
preprocessing, segmentation, feature extraction and classification. During data preprocessing, 
methods of image correction, normalization and coordinates transformation are applied to the 
acquired data so that the image quality and consistency are ensured. During segmentation, data are 
manually or automatically partitioned into multiple segments based on anatomy or physiology. In 
this way, the regions of interest (ROIs) are well-defined, making it possible to extract features from 
ROIs. Finally, these features will be fed into the classification step so that classifiers are able to 
learn useful diagnostic information and propose predictions of AD for given test subjects. Though 
highly reliable and explainable, these steps could be sophistic and lowly integrated, as different 
platforms are used in different steps of these algorithms. In addition, the automatic and accurate 
segmentation of brain is still an open question, leading to more uncertainty of the extracted features. 
 
Benefited from the rapid development of computer science and the accumulation of patients’ data, 
deep learning has become a popular and useful technique in the field of medical imaging recently. 
Therefore, we propose to use deep learning framework in our work to implement the feature 
extraction and classification steps. The general applications of deep learning in medical imaging are 
mainly about feature extraction, image classification, object detection, segmentation and 
registration [21]. Among the deep learning networks, convolutional neural networks (CNNs), 
recurrent neural networks (RNNs), deep belief networks (DBNs), auto-encoders (AEs) and 
restricted Boltzmann machines (RBMs) are common choices. Take CNN-based AD diagnosis as an 
instance, different people used different architectures. Hosseini-Asl et al. built a 3D-CNN based on 
a 3D convolutional auto-encoder, which takes fMRI images as input and gives prediction of 
AD/MCI/NL [22], while Sarraf et al. used a LeNet-5-like CNN to classify AD from NL based on 
fMRI [23]. Multi-modality classification was also implemented in CNN. Liu et al. conduced a T1-
MRI+FDG-PET based cascaded CNN, which utilized a 3D CNN to extract features respectively for 
each modality and adopted another 2D CNN to combine multi-modality features for task-specific 
classification [24]. 
 
In this work, we propose a multi-modality AD classifier, which takes MRI and PET images around 
the hippocampal area as input, and give predictions in the NL/AD task, the NL/pMCI task and the 
sMCI/pMCI task. The main contributions of our work are listed below: 
(1) We showed that segmentation of the key substructures, such as hippocampi, is not a necessary 
step in CNN-based classification. 
(2) We showed that a ROI enclosing the hippocampal area provides enough information to give 
reference to AD diagnosis. 
(3) We conducted a 3D VGG variant CNN to implement single modality AD diagnosis.  
(4) We introduced a new framework to fuse complementary information from multiple 
modalities in our proposed network, for the classification tasks of NL/AD, NL/pMCI and 
sMCI/pMCI. 
 
The rest of the paper is organized as follows. Section 2 describes the datasets. Section 3 presents 
the classification algorithm of CNN and VGG neural network. In Section 4, we elaborate on the 
methodologies of the VGG variant networks for the different classification tasks and provide the 
results. Section 5 presents the discussion and conclusion of this work.  
 
2. Material 
In this section, we presented the multi-modality image datasets that were used in this study, the data 
pre-processing methods. MRI and PET are two essential modalities that are widely used for AD 
diagnosis. Biomarkers of Alzheimer’s disease (AD) extracted from MRIs is an active research area, 
whose importance in AD was underlined by its inclusion in criteria for AD diagnosis. In particular, 
the decrease of hippocampal volume is one of the best-established biomarkers used in research 
studies to stage the progression of Alzheimer's disease (AD) pathology in the brain of patients across 
the spectrum of the disease [25]. Therefore, the hippocampi are the most studied region of AD, 
which are so far the only MRI biomarker that has been qualified for enrichment of clinical trials 
[26]. For PET images, published studies indicate that AD may cause the decline of 18-Fluoro-
DeoxyGlucose (FDG) uptake in the temporoparietal cortex, as well as brain atrophy in the medial, 
basal, lateral temporal lobes, the medial and lateral parietal cortices. As a result, the ROI of 
metabolic changes in cortices, especially temporal lobes with FDG biomarkers may help AD 
diagnosis [27,28,29]. When dealing with PET images, we tried different ROIs containing 
hippocampi and cortices. 
 
2.1 Image Acquisition  
The datasets we used in this work were downloaded from the Alzheimer’s Disease Neuroimaging 
Initiative (ADNI) database, which is publicly available on the website http://adni.loni.usc.edu. 
ADNI is a longitudinal multicenter study designed for the AD detection at the earliest possible stage 
(pre-dementia) and tracking of progression of Alzheimer's disease (AD) with biomarkers. The study 
comprises four main phases, the initial five-year study (ADNI-1) was extended by two years in 2009 
by a Grand Opportunities grant (ADNI-GO), and in 2011 and 2016 by further competitive renewals 
of the ADNI-1 grant (ADNI-2, and ADNI-3, respectively). The participant subjects were recruited 
across North America during each phase of the study, agreed to complete a variety of imaging and 
clinical assessments, and the results are shared by ADNI through the USC Laboratory of Neuro 
Imaging's Image and Data Archive (IDA). ADNI helps researchers to collect, validate and utilize 
data, including magnetic resonance imaging (MRI) and Positron Emission Tomography (PET) 
images, genetics, cognitive tests, CSF and blood biomarkers as predictors of the disease, to measure 
and track the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD). 
 
In this work, we used the T1-weighted magnetic resonance (MR) imaging data and the 18-Fluoro-
DeoxyGlucose PET (FDG-PET) imaging data from the baseline and follow-up visit in ADNI. The 
MRI images were acquired from volumetric 3D Accelerated MPRAGE and SPGR, and the FDG-
PET images were acquired 30–60 min post-injection. To integrate the PET images for each 
acquisition, we calculated the averaged intensity of images after intensity normalization with 
different post-injection time to generate a single PET image in this acquisition. One can visit the 
ADNI website for more details about the acquisition steps of MRI and PET [30].  
 
We used two datasets in this work. To verify the effect of segmentation on classification, a larger 
dataset containing only MRI images, called the MALPEM dataset [31], and a smaller dataset 
containing MRI and corresponding PET images, called Paired dataset were chosen. 
 
In the MALPEM dataset, T1-weighted images were segmented into 138 anatomical regions using 
multi-atlas label propagation with expectation-maximization (MALPEM), which is a software 
package to perform whole-brain segmentation of T1-weighted MRI images, available on the website 
https://biomedia.doc.ic.ac.uk/software/malp-em/ [31]. In all, 2861 subjects containing both MRI 
images and segmentation labels were obtained, including AD and NL. All subjects we studied are 
summarized in Table 1. 
 
About the Paired dataset, we took the following steps to screen out the corresponding MRI and PET 
images of the patient taken in the same period. Firstly, for each patient, we picked up all the 
corresponding MRI images and FDG-PET images. For each image, the data column contains the 
patient ID and the acquisition date, by which we can determine the time interval between different 
MRI and PET images. Then, we merged MRI and PET images for the same patient and combined 
the nearest MRI and PET images according to the acquisition date. MRI and PET images were 
Table 1 Summary of the studied subjects of MALPEM dataset. 
Diagnosis Number Age Gender(M/F) MMSE 
AD 1355 76.13±7.50 772/583 21.89±4.33 
NL 1506 76.04±5.81 776/730 29.04±1.20 
 
Table 2 Summary of the studied subjects from the Paired dataset. 
Diagnosis  Number Age Gender(M/F) MMSE 
AD 647 76.36±7.21 361/287 24.84±2.65 
pMCI 326 75.00±7.06 212/114 27.22±1.74 
sMCI 441 74.37±7.40 297/144 28.15±1.55 
NL 731 76.16±6.02 421/310 28.99±1.20 
 
regarded as paired multi-modality images if the two images were taken within one year. After that, 
we manually checked the patients' diagnosis to ensure the two images point to same diagnosis. After 
removing pairs of MRI and PET images captured with interval more than one year, we got the 
remaining MRI and PET images as subjects with multi-modality images as the Paired dataset for 
classification. After data filtering described above, 647 AD subjects, 1391 MCI subjects and 731 
NL subjects were acquired. 
 
The MCI subjects were classified into progressive mild cognitive impairment (pMCI) and stable 
mild cognitive impairment (sMCI) in this work. According to the judging criteria we mentioned 
before, MCI is defined as pMCI if it is developed to AD within three years for the current MCI 
patient, or defined as sMCI if it is not developed to AD for at least three years. Besides, subjects 
without follow-up data for more than three years were ignored. Through this standard, we identified 
326 pMCI subjects and 441 sMCI subjects. 
 
Finally, we acquired imaging data from 1211 ADNI participants including 647 AD, 767 MCI (326 
MCI converters (pMCI) and 441 MCI non-converters (sMCI)), 731 NL subjects. All the subjects 
we studied are summarized in Table 2. 
 
2.2 Data Processing 
The pre-processing of MRI and PET images was implemented by zxhtools, which is available on 
the website http://www.sdspeople.fudan.edu.cn/zhuangxiahai/0/zxhproj/. Based on this platform, 
several image registration and segmentation tools have been developed. In this work, zxhreg and 
zxhtransform were mainly used for the registration of the radiological images. Before proceeding 
any further, all MRI images were re-oriented and resampled to the resolution of 221 × 257 × 221 
and the spacing of 1 × 1 × 1 mm3. 
 
The significant position hippocampi hold could be stated from the description in the previous 
sections. Therefore, the hippocampal area in MRI and PET images were located to be the region of 
interest (ROI) in this work. In addition, due to the limitation of GPU RAM and computation ability 
in VGG network, we cropped the region of interest to represent the whole image, which is centered 
in the center point of hippocampi and dilate from it. 
 
For the MALPEM datasets with segmentation result, we could directly calculate the center point of 
the hippocampi’s center point. For the Paired dataset, we obtained the central points of MRI images 
through the following steps. Firstly, the location of the hippocampi is marked on MRI images in the 
MALPEM dataset, thus the center of hippocampi can be calculated. Secondly, one MRI image from 
the Paired dataset was selected as template of hippocampi’s center point. The images from the 
MALPEM dataset were affine-registered to the template image, and the center points were averaged 
to identify the center point of hippocampi in template image. Finally, we registered the template 
image to other MRI images in the Paired dataset using affine-registration and used the 
corresponding affine matrix to determine the center point for each MRI image. Furthermore, each 
PET image was rigid-registered to respective MRI image for the identification of hippocampi’s 
center point in PET images. After registration, PET images were transformed to a uniform isotropic 
spacing of 1 × 1 × 1 mm3.  
After confirming the center point of ROI, we dilated and cropped ROI as big as 96 × 96 × 48 voxels 
of MRI images from the center point of hippocampi. In the MALPEM dataset, in order to verify the 
effect of segmentation on classification, we processed the cropped ROI and corresponding labels 
through three different treatments and obtained three datasets: Raw, WithSeg and Bin. The Raw 
dataset contains MRI raw images only, which received all the imaging information of the 
hippocampi and surrounding areas. The WithSeg dataset is made up of MRI images masked by 
binary labels, it takes original images and segmentation results as input. The Bin dataset is made up 
of binary hippocampi segmentation labels, only indicating information about the shape and volume 
of the hippocampi. Through the comparison of classification performance using these three datasets, 
it can show whether the segmentation results have an important effect on AD diagnosis. The three 
datasets are shown in Figure 3 A, B, C. 
 
When it comes to PET images in the Paired dataset, we used two different ways to generate the 
patch of PET images. The dataset generated by the first way is called the Origin dataset, using 
exactly the same ROI with the MRI, which means that voxels of PET have the same spacing with 
corresponding origin MRI. The dataset generated by the second way is called the Dilated dataset, 
which has the same ROI center and orientation with corresponding MRI but has 2 × 2 × 2 mm3 
spacing. In other words, the Dilated dataset has 8 times of the volume but a lower spatial resolution, 
and the entire temporal lobes of both sides are included. 
 
After data processing, the dataset was randomly split into the training set and the testing set 
according to patient ID to ensure that all subjects of the same patient only appear in the training set 
or the testing set at the same time. Finally, 70% of the dataset were used as the training set, 10% as 
the validation set, and 20% as the testing set by random sampling. 
 
3. Methodology  
In this section, we introduce the proposed classification algorithm of a convolution-based neural 
network in detail. Convolutional neural network (CNN) [32] is a deep feedforward neural network 
composed of multi-layer artificial neurons, having excellent performance in large-scale image 
processing. Unlike traditional methods of manually extracted features of radiological images, CNNs 
are used to learn general features automatically. CNNs are trained with back propagation algorithm, 
usually consisting of multiple convolutional layers, pooling layers and fully connected layers, 
connecting to output unit through full connection layers or other methods. Compared to other deep 
feedforward networks, CNNs have fewer connections and smaller number of parameters due to the 
weight of the convolution kernel sharing and are therefore easier to train and more popular. 
 
With CNNs becoming popular in the computer vision field, a number of attempts have been made 
to improve the original network structure to achieve better accuracy. VGG [33] is a neural network 
based on improved AlexNet [34] in 2014, achieved a 7.3% Top-5 error rate in the 2014 ILSVRC 
competition [35]. VGGs further deepen the network based on AlexNet by adding more 
convolutional layers and pooling layers. A demonstration of VGG16 is shown in Figure 1, it is a 
very deep network consists of several convolution layers followed by max pooling layers. Different 
from traditional CNNs, VGGs evaluate very deep convolutional networks for large-scale image 
classification, which come up with significantly more accurate CNN architectures and can achieve 
excellent performance even when used as a part of a relatively simple pipelines. 
4. Experiments  
In this section, we used several parts of work as shown below to introduce our experiment. In 
Section 4.2, we used different types of data to determine the proper datatype and ROI by two 
experiments. In Section 4.2.1, the classification results by datasets with/without segmentation were 
compared to show whether segmentation is necessary or not in CNN. In Section 4.2.2, different 
spacings of PET images were tested, and we found that the classification model using a small 
spacing and a small region has similar performance with a large spacing and a large region. In 
Section 4.3, we constructed a VGG-like multi-modality AD classifier, which took both T1-MRI and 
FDG-PET data as input and gave a prediction. In Section 4.4, we trained and tested our network 
with pMCI and sMCI data. Finally, Section 4.5 compared our method with state-of-the-art methods. 
 
 
 
Figure 1 VGG16, which is a very deep network consisting of 13 convolution layers, 5 max 
pooling layers and 3 fully connected layers. Several convolution layers are followed by max 
pooling layer, reducing the dimensionality. In this figure, the original image with pixel size 224 
× 224 formed a feature map of size 7 × 7 × 512 after multiple convolutions and pooling layers, 
obtaining classification result after fully connected and Softmax layers. 
4.1 Experimental setup 
All the networks mentioned above were constructed with the help of TensorFlow [36] on Python 
platform. Training procedures of the networks were conducted on a PC with Nvidia GTX1080Ti 
GPU. During training, batch normalization [37] was deployed in convolution layers and dropout 
[38] was deployed in full-connection layers to avoid overfitting. To accelerate the training process 
and to avoid local minimums, we used ADAM algorithm [39] as the training optimizer. Batch size 
was set to 16 when training single modality networks and 8 when training multi-modality networks. 
In training it took one to several minutes per epoch, with respect to different datasets and network 
architectures, as an ordinary training schedule contains 150 epochs. In most cases, the training loss 
would converge in 30 epochs. During training, the parameters of the networks were saved every 10 
epochs. These parameters were used to run on the validation set later. During the validation, 
accuracies and the receiver operating characteristic (ROC) curves of the classification were 
calculated, and the parameters with the highest accuracy and area under ROC (AUC) was chosen to 
be the final classifier. 
 
4.2 Data Types Analysis 
In order to determine the proper data type for network to train, we designed two experiments to 
evaluate the classification performance of models when feeding with different datatypes in this part, 
as listed below: 
(1) Testing whether segmentation is needed in the MRI images. We used three different datasets, 
with or without segmentation, to show that segmentation is not necessary in CNN. 
(2) Finding a proper PET ROI. Different spacings of PET images were tested, as we found that the 
classification model using a small spacing and a small region has similar performance of that 
with a large spacing and a large region. 
 
 
Figure 2 The architecture of the single modality classifier. 
All the models mentioned above were trained in the same network, as shown in Figure 2. The input 
resolution was 96 × 96 × 48 voxels, and the network contained 8 convolution layers, 5 pooling 
layers and 3 full connection layers. The output was given through the softmax function.  
 
4.2.1 Influence of Segmentation 
In this part, we compared the classification results using datasets with/without segmentation to show 
that segmentation is not necessary in CNN. As mentioned above, segmentation takes an important 
role in traditional classification methods, for it labels voxels with anatomy meanings and defines 
ROIs. However, segmentation is also known for time-consuming. Meanwhile, it’s possible that 
CNN can extract useful features directly from raw images, as lots of CNNs show a strong ability of 
locating keypoints in object detection tasks in natural image processing [40, 41]. However, 
segmentation can help in many ways, including locating ROIs, specifying the morphologic and 
volumetric features, blocking out confusing tissues, and speeding up the convergence when training 
the models.  
 
 
Figure 3 Demonstrations of the datasets and ROI. A, B, C are generated from the same MRI 
image to demonstrate the Bin (A), WithSeg (B), and Raw (C) dataset. A is a binary image of 
the segmentation of hippocampi. B is a raw image masked by hippocampal segmentation. C 
is a cropped raw image. D, E, F are generated form the same PET image to demonstrate the 
Origin (E) and Dilated (F), as D is the PET image. E is cropped from D, and F is down sampled 
from D. G, H, I demonstrates the selected ROI, as G is horizontal plane, H is sagittal plane, 
and I is coronal plane. 
 
We segmented the AD and NL subjects of T1-MRI images with MALP-EM algorithm [31] and 
obtained the MALPEM datasets, including 2861 subjects that contain both MRI images and 
segmentation. In our assumption, segmentation itself indicates the shapes, volumes, textures and 
relative locations of hippocampal areas. Therefore, the data obtained from the subjects was 
generated three different datasets, as shown in Figure 3 A, B, C. The Raw dataset contains MRI 
raw images only; the Bin dataset is made up of binary hippocampal segmentation labels and the 
WithSeg dataset is made up of MRI images masked by binary labels. 
 
For each model trained from these datasets, accuracy and AUC were calculated, as listed in Table 
3. Among all three models, the model trained from the Raw dataset performed best, followed by the 
WithSeg dataset. Model trained from the Bin dataset also gave favorable prediction, though inferior 
to the Raw dataset and the WithSeg dataset. The results indicate that segmentation do contain 
information needed for classification. However, segmentation is not necessary for the classification 
task since CNN is able to learn useful features without labeling the voxels. In addition, features 
from region out of hippocampi also add further information in separating AD patients apart from 
normal ones. 
 
4.2.2 PET ROI Determination 
In this part, we discussed the ROI selection of PET images. We tested different spacings of PET 
images to show which ROI is better for PET in classification. Due to the limitation of GPU RAM 
and computation ability, it was difficult to take the entire image as the network input, as our 
proposed network only took a region as big as 96 × 96 × 48 voxels, which was still 2.91 times of 
the input size of original VGG (224 × 224 pixels × 3 channels). Hence, the selection of ROI took 
an important role, as only the features in the ROI would be taken. When regarding to MRI images, 
the selection of ROI was with little doubt, for the hippocampal area was long to be the main concern 
of AD research [26, 27]. However, the ROI of PET images varied, as studies also attached 
significance to metabolic changes in cortices, especially temporal lobes [28, 29].  
 
Table 3 Summary of the models trained from the Bin, WithSeg and Raw datasets for NL/AD 
task. The MALPEM dataset was used. 
MRI ROI ACC SEN SPE AUC 
Bin 76.57% 83.87% 71.51%  84.24%  
WithSeg 79.21% 76.61% 81.01%  84.63%  
Raw 84.82% 87.90%  82.68% 87.47%  
 
Table 4 Summary of the models trained from the Origin PET and the Dilated PET datasets 
for NL/AD task. The Paired dataset was used. 
PET ROI ACC SEN SPE AUC 
Origin PET 89.11% 90.24%  87.77% 92.69%  
Dilated PET 89.44% 87.20% 92.09%  90.35% 
 
To verify the effect of ROI containing temporal lobes on classification, we generated two datasets 
from the PET images, the Origin dataset and the Dilated dataset, as shown in Figure 3 D, E, F. The 
Origin dataset uses exactly the same ROI with the MRI ROI, which means that voxels of a pair of 
MRI and PET images have the same spacing and the same orientation and are voxelwisely aligned. 
The Dilated dataset has the same ROI center and orientation with the MRI ROI but has a 2 × 2 × 2 
mm3 spacing, in which the entire temporal lobes of both sides are included. In short, the Dilated 
dataset has 8 times of the volume but a lower spatial resolution than the Origin dataset. 
 
Two models were trained from these two datasets, and metrics were calculated, as listed in Table 
4. As is shown, the performance of two models were relatively close. Although the Origin dataset 
has higher spatial resolution, the Dilated dataset contains more features. Further, when considering 
multi-modality classification tasks, the Origin dataset might be better, because PET images in the 
Origin dataset were voxelwisely aligned with paired MRI images, which could help better locate 
spatial features. Therefore, we chose the same ROI in MRI and PET images, as the regions shown 
in Figure 3 G, H, I. 
 
 
Figure 4 The architecture of the multi-modality network A and B. 
 
4.3 Multi-modality AD Classifier 
In this part, we constructed a VGG-like multi-modality AD classifier and compared the results with 
single modality models. When using single modality, the information that a classifier can obtain is  
limited, as one medical imaging method can only profile one or several aspects of AD pathological 
changes, which is far to be complete. For example, T1-MRI images provide high-resolution brain 
structure but give little information about the functional information about the brain. Meanwhile, 
FDG-PET images are fuzzy, but do better in revealing the metabolic activity of glucose in the brain. 
In order to take as more information of the brain as possible, we introduced a classification 
framework to fuse multi-modality information.  
 
To prepare the dataset, we firstly matched MRI with PET images and translated them into same 
world coordinates. After that, paired images of MRI and PET were aligned by rigid registration to 
ensure that voxels of the same indices in the paired images represent the same part of the brain. 
After that paired images were cropped according to the center point of MRI images, the Paired 
dataset were obtained.  
 
To implement the multi-modality classifier, we proposed two different network architectures, as 
shown in Figure 4. In Figure 4 A, MRI and PET images were used as two parallel channels, in 
which way paired images were stacked into 4D images. In these 4D images, the first three 
dimensions represent the three spatial dimensions, and the fourth dimension represents different 
channels. In Figure 4 B, MRI and PET images have separate entrances, as they are convolved 
respectively in two separate VGG-11s, and the extracted features are concatenated together. This 
network was trained in two protocols, denoted by B1 and B2. In B1, model was trained with the 
weights shared for the convolutional layers. Meanwhile in B2, the weights of two VGG-11s were 
updated separately in training. 
 
Method A B1 B2 
 ACC SEN SPE AUC ACC SEN SPE AUC ACC SEN SPE AUC 
NL/AD 87.79% 85.98% 89.93% 89.42% 90.10% 90.85% 89.21% 90.84% 89.44% 89.02% 89.93% 92.01% 
NL/pMCI 70.49% 73.17% 65.00% 71.63% 79.10% 87.80% 61.25% 76.84% 82.38% 87.20% 72.50% 81.64% 
sMCI/pMCI 65.28% 65.63% 65.00% 65.81% 65.28% 54.69% 73.75% 66.82% 72.22% 73.44% 71.25% 77.49% 
 
 
Table 5 Summary of the models trained from single modality protocols and three multi-modality 
protocols for NL/AD task. The Paired dataset was used. 
Method ACC SEN SPE AUC 
MRI 81.19% 79.27% 83.45% 83.67% 
PET 89.11% 90.24% 87.77% 92.69% 
A 87.79% 85.98% 89.93% 89.42% 
B1 90.10% 90.85% 89.21% 90.84% 
B2 89.44% 89.02% 89.93% 92.01% 
 
Table 6 Summary of the models trained from three multi-modality protocols for NL/AD task, 
NL/pMCI task and sMCI/pMCI task. The Paired dataset was used.  
 
We trained five models based on paired MRI and PET images, as two single modality models, MRI 
and PET, and three multi-modality models, A, B1 and B2. The results are shown in Table 5 and 
Figure 5 A. As shown in Table 5, multi-modality classifiers have better performance than single 
modality classifiers. Besides, among three multi-modality models, model trained with protocol B1 
has the highest accuracy and sensitivity, while model trained with protocol B2 has the highest 
specificity and AUC. 
 
Figure 5 ROC curves of different models. A, B, C are ROC curves for three tasks using different 
models. A shows the ROC curve for NL/AD task using model trained from protocol A, B1 and 
B2, while B shows the ROC curve for NL/pMCI task, C shows the ROC curve for sMCI/pMCI 
task, respectively. 
 
4.4 Classification of sMCI/pMCI and NL/pMCI tasks 
In this part, we trained and tested our network with pMCI and sMCI subjects. Simply classifying 
AD patients from normal controls is relatively easy, but doesn’t have much guidance significance, 
because the development of AD can be spotted by the behavior changes of patients. In addition, 
there are lots of alternative indicators in diagnosis. Therefore, the preclinical diagnosis of AD seems 
to be more meaningful, as one of the main concerns is telling progressive MCI from stable MCI and 
normal controls. As pMCI would progress to AD, classifying pMCI could give a prediction of the 
development of MCI, and thus have high reference value and clinical meaning.  
 
According to Lin et al. [42], the models that trained from the NL/AD training set perform better 
than the models trained from the sMCI/pMCI training set in the sMCI/pMCI task. Therefore, we 
trained models with the NL/AD training set and tested the models with the NL/pMCI testing set and 
the sMCI/pMCI testing set, as the results shown in Table 6 and Figure 5. Though B1 performed 
slightly better in NL/AD task, B2 was superior in NL/pMCI and sMCI/pMCI tasks. These results 
indicate that features of MRI and PET turns to be more consistent when dementia is highly 
developed, as convolutional kernels of model B1 shared weight while those of B2 didn’t.  
 
4.5 Comparison with Other Methods 
In this part, we compared our method with those that were used in previous literature. We first 
compared our method with a state-of-the-art research using 3D CNN-based multi-modality models 
as well [42]. Liu et al. proposed a multi-modality cascaded CNN. They used the patch-based 
information of a whole brain to train or test their models and they integrated the information from 
the two modalities by concatenating the feature maps [43]. In this work, we used the hippocampal 
area to verify the connection between AD and the multi-modality structure of the hippocampi. Table 
7 shows the results of the two methods. Our method failed to outperform the cascaded CNN model 
in NL vs. AD task, but it achieved higher accuracy and AUC in the task of distinguishing pMCI 
from normal subjects. It should be noted that our models use the data from multiple facilities, our 
models take only the hippocampal area as an input. These would influence the behavior of our 
method. 
 
Moreover, we compared our results with an extended CNN network using 2.5D (2D slices in 
different directions) MRI as an input. Lin et al., chose to reduce the amount of input by slicing the 
Table 7 Comparison of our proposed method and Liu’s multi-modality method. 
Method Subjects Modality NL vs. AD NL vs. pMCI 
ACC SEN SPE AUC ACC SEN SPE AUC 
Liu et al. 
2018 
93 AD +  
204 MCI +  
100 NL 
MRI 84.97% 82.65% 87.37% 90.63% 77.84% 76.81% 78.59% 82.72% 
PET 88.08% 90.70% 85.98% 94.51% 78.41% 77.94% 78.70% 85.96% 
Both 93.26% 92.55% 93.94% 95.68% 82.95% 81.08% 84.31% 88.43% 
Proposed 
method 
465 AD +  
567 MCI +  
480 NL 
MRI 81.19% 79.27% 83.45% 83.67% - - - - 
PET 89.11% 90.24% 87.77% 92.69% - - - - 
Both 89.02% 89.93% 92.01% 89.02% 87.46% 90.73% 80.61% 90.31% 
 
data instead of taking the hippocampi out as we did [42]. What’s more, other multi-modality 
attempts were taken into account. Tong et al. used nonlinear graph fusion to join the features of 
different modalities [44]. In Zu et al.’s study, the feature selection from multiple modalities were 
treated as different learning tasks and a multi-kernel support vector machine (SVM) was adopted to 
fuse the selected features [45]. Liu et al. used stacked autoencoders (SAE) with a masking training 
strategy [43]. Jie et al. used manifold regularized multitask feature learning method to preserve both 
the relations among modalities of data and the distribution in each modality [46]. Li et al. used deep 
learning framework to predict the missing data [47]. Table 8 compares the previous multi-modality 
models with our proposed models. Among all the results listed below, our results are favorable in 
the NL/AD task and are the best in the sMCI/pMCI task. 
 
5. Discussion and Conclusion 
In this work, we proposed a VGG-like framework with several instances to implement a T1-MRI 
and FDG-PET based multi-modality AD diagnosing system. The ROI of MRI was selected to be 
the hippocampal area, as it is most frequently studied and is thought to be of the highest clinical 
value. Through the experiments, we proved that segmentation is not necessary in CNN, which is 
different from traditional machine learning based methods. However, registration is still needed, for 
the images we used were taken from different facilities and had different spacings and orientations. 
Although models obtained from the datasets Origin and Dilated had similar performance, the ROI 
of PET was chosen to be the same as MRI’s, because the ROI of Origin was voxelwisely aligned 
with the ROI of paired MRI. In short, only hippocampal areas were used as ROIs in our proposed 
methods, which is the main difference between our study and the previous ones. Thus, we may 
construct a deeper network as well as feed it with higher resolution medical images, as we suppose 
that the hippocampal area itself can serve as a favorable reference in AD diagnosis. 
Table 8 Comparison of our proposed method and published AD diagnosis methods. 
Method Subjects NL vs. AD sMCI vs. pMCI 
ACC(%) SEN SPE AUC ACC(%) SEN SPE AUC 
Lin et al. 
2018 
93 AD + 204 MCI 
+ 100 NL 
88.79% - - - 73.04% - - - 
Tong et al. 
2017 
37 AD + 75 MCI 
+ 35 NL 
88.6% - - 94.8% - - - - 
Zu et al. 
2016 
51 AD + 99MCI + 
52 NL 
95.95% - - - 69.78% - - - 
Liu et al. 
2015 
85 AD + 168 MCI 
+ 77 NL 
91.40% 92.32% 90.42% - - - - - 
Jie et al. 
2015 
51 AD + 99 MCI 
+ 52 NL 
95.03% - - - 68.94% - - - 
Li et al. 
2014 
93 AD + 204 MCI 
+ 101 NL 
92.87% - - 89.82% 72.44% - - 70.14% 
Proposed 
method 
465 AD + 567 
MCI + 480 NL 
90.10% 90.85% 89.21% 90.84% 76.90% 68.15% 83.93% 79.61% 
 
Since ROI was selected, we introduced multi-modality method to the classifier. Two networks and 
three types of models were proposed as listed in Table 9. Among these three types of models, the 
model trained from protocol B1, which means that MRI and PET images have separate inputs for 
convolutional layers, but shared convolutional kernels, performed the best in NL/AD task. One 
possible explanation is that MRI and PET images have some common features, and sharing weight 
helped models to extract these features during the training process. Furthermore, we used proposed 
networks to train NL/pMCI and sMCI/pMCI classifiers, both of them indicated the potential of 
preclinical diagnosis using our proposed methods. 
 
We also followed Lin et al.’s lead and used the model trained by NL/AD subjects to distinguish 
sMCI and pMCI [42]. The results were better than that of the model trained by sMCI and pMCI 
themselves, as shown in Table 9. This is reasonable because the features of sMCI and pMCI are 
close to each other in the feature space and hard to differentiate while those of NL and AD are 
widely spread which makes the classification a lot easier. The same conclusion can be obtained by 
testing the NL/AD model on the NL/pMCI dataset. Specifically, when NL/AD model was used, the 
accuracy reached 76.90% for sMCI/pMCI and 87.46% for NL/pMCI, which were about 5 percent 
higher than the accuracy obtained using their own models. These results are also better than those 
of Lin et al.’s. 
 
Regarding to the future work, first we only used two modalities, i.e., T1-MRI and FDG-PET, as 
input in this work. However, including new modalities can be easily implemented based on the 
proposed networks. The interested new imaging modalities incllude T2-MRI [48], 11C-PIB-PET 
[49], and other PET agents such as for amyloid protein imaging [50]. Also, the features extracted 
by CNN are hard for human beings to comprehend, while some methods like attention mechanism 
[51] are able to visualize and analyze the activation maps of the model, in which ways future work 
could be done to improve the classification performance and discover new medical imaging 
biomarkers. 
 
To conclude, we have proposed a multi-modality CNN-based classifier for AD diagnosis and 
prognosis. VGG backbone, which is deeper than most similar studies, has been used and explored. 
The accuracy of models reached 90.10% for NL/AD task, 87.46% for NL/pMCI task and 76.90% 
for sMCI/pMCI task. As we only used hippocampal area as ROI, our work indicates that small but 
high-resolution ROI can have high reference values if selected properly. 
 
Task Training Set Testing Set B1 B2 
   ACC SEN SPE AUC ACC SEN SPE AUC 
NL/pMCI NL/AD NL/pMCI 87.46% 90.73% 80.61% 87.61% 87.13% 87.80% 85.71% 90.31% 
NL/pMCI NL/pMCI NL/pMCI 79.10% 87.80% 61.25% 76.84% 82.38% 87.20% 72.50% 81.64% 
sMCI/pMCI NL/AD sMCI/pMCI 73.60% 66.67% 79.17% 75.59% 76.90% 68.15% 83.93% 79.61% 
sMCI/pMCI sMCI/pMCI sMCI/pMCI 65.28% 54.69% 73.75% 66.82% 72.22% 73.44% 71.25% 77.49% 
 
Table 9 Comparison of the performance of models trained from the NL/AD training set and the 
tasks’ own training set. The Paired dataset was used. 
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